# Boxplot Interpretation

The information explained in the boxplot indicates the following:

| No. | Properties                | Q1 (25%) | Q2 (Median) | Q3 (75%) | IQR  | Min     | Max      | Outlier Range                                | Biological Significance                                                                                                                                                                                                                                                                               |
| :-- | :------------------------ | :------- | :---------- | :------- | :--- | :------ | :------- | :------------------------------------------- | :------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| 1.  | **AliphaticRings** | 0.00     | 0.00        | 1.00     | 1.00 | 0.00    | ~30      | > 2.5 (3-30)                                 | Contribute to 3D shape, rigidity, and lipophilicity; influence binding and pharmacokinetics.                                                                                                                                                                                                |
| 2.  | **AromaticHeterocycles** | 0.00     | 0.00        | 0.00     | 0.00 | 0.00    | ~5       | > 0.00 (1-5)                                 | Very common in drugs, affecting interactions, activity, and metabolism. Most lack, some have many.                                                                                                                                                                                          |
| 3.  | **AromaticProportion** | 0.00     | 0.36        | 0.55     | 0.55 | ~0.00   | ~1.00    | None                                         | Influences rigidity, planarity, and electronic properties; affects interactions and stability.                                                                                                                                                                                                |
| 4.  | **AromaticRings** | 0.00     | 1.00        | 2.00     | 2.00 | 0.00    | ~12      | > 5 (6-12)                                   | Aromaticity affects stability, electronic properties, and molecular interactions. Common in drugs.                                                                                                                                                                                          |
| 5.  | **FormalCharge** | 0.00     | 0.00        | 0.00     | 0.00 | ~-5     | ~3       | Not 0 (-5 to -1, 1 to 3)                     | Critical for interactions with charged environments; impacts membrane permeability. Majority are neutral.                                                                                                                                                                                           |
| 6.  | **FractionCSP3** | 0.18     | 0.42        | 0.73     | 0.55 | ~0.00   | ~1.00    | None                                         | Higher sp3 indicates more 3D structure, better solubility, less promiscuous binding. Wide distribution shown.                                                                                                                                                                                         |
| 7.  | **HalogenCount** | 0.00     | 0.00        | 0.00     | 0.00 | 0.00  | ~24      | > 0.00 (1-24)                                | Halogens influence lipophilicity, reactivity, and binding. Majority have zero, but some are highly halogenated.                                                                                                                                                                                             |
| 8.  | **HBAcceptors** | 2.00     | 3.00        | 5.00     | 3.00 | ~0.00   | ~68      | > 9.5 (10-68)                                | Critical for molecular interactions and solubility; too many can impact permeability.                                                                                                                                                                                                     |
| 9.  | **HBDonors** | 0.00     | 1.00        | 2.00     | 2.00 | 0.00    | ~32      | > 5 (6-32)                                   | Crucial for molecular recognition, binding, solubility. Too many hinder permeability.                                                                                                                                                                                                       |
| 10. | **HeavyAtoms** | 11.00    | 16.00       | 23.00    | 12.00 | ~0      | ~125     | > 41 (42-125)                                | Proxy for molecular size and complexity; impacts solubility, permeability, and synthesis.                                                                                                                                                                                                   |
| 11. | **Heteroatoms** | 2.00     | 4.00        | 6.00     | 4.00 | ~0      | ~75      | > 12 (13-75)                                 | Non-carbon/hydrogen atoms that define a molecule's properties, reactivity, and biological interactions (e.g., O, N, S, P). Affects polarity, H-bonding, and metabolism.                                                                                                                       |
| 12. | **LogP** | 1.15     | 2.37        | 3.65     | 2.50 | ~-45    | ~20      | < -40 or > 15 (~-45 to -18, ~15 to 20)      | Octanol-water partition coefficient, a measure of lipophilicity. Important for membrane permeability and distribution. Moderate LogP is often desired for drug-likeness.                                                                                                                   |
| 13. | **LogS_ESOL** | -4.11    | -2.88       | -1.80    | 2.30 | ~-17    | ~19      | < -14 or > 4 (~-17 to -12, ~4 to 19)         | Estimated solubility in water. Higher values indicate better solubility. Crucial for drug formulation and bioavailability.                                                                                                                                                                  |
| 14. | **MolarRefractivity** | 43.81    | 63.67       | 91.06    | 47.25 | ~0      | ~430     | > 162.9 (~163-430)                           | A measure of the total polarizability of a molecule. Related to dispersion forces and molecule size. Important for drug-receptor interactions.                                                                                                                                            |
| 15. | **Molecular Weight** | 165.21   | 240.30      | 343.04   | 177.83 | ~0      | ~2000    | > 618 (~620-2000)                            | Total mass of a molecule. Affects absorption, distribution, metabolism, and excretion (ADME) properties. Often a key filter in drug discovery (e.g., Lipinski's Rule of Five suggests MW < 500 Da).                                                                                    |
| 16. | **MolecularComplexity** | 0.91     | 1.14        | 1.33     | 0.42 | ~0.15   | ~2.00    | < 0.25                                       | A metric quantifying the structural complexity of a molecule. Often relates to synthetic accessibility and intellectual property. Higher complexity can mean more difficult synthesis.                                                                                             |
| 17. | **NegativeCharges** | 0.00     | 0.00        | 0.00     | 0.00 | 0.00    | ~5       | > 0.00 (1-5)                                 | Number of negatively charged atoms. Influences electrostatic interactions, membrane permeability, and binding to positively charged regions of targets. Most drug-like molecules are uncharged.                                                                                             |
| 18. | **PhenolicGroups** | 0.00     | 0.00        | 0.00     | 0.00 | 0.00    | ~25      | > 0.00 (1-25)                                | Hydroxyl groups directly attached to an aromatic ring. Can act as hydrogen bond donors and are often involved in metabolism and reactivity.                                                                                                                                            |
| 19. | **PositiveCharges** | 0.00     | 0.00        | 0.00     | 0.00 | 0.00    | ~4       | > 0.00 (1-4)                                 | Number of positively charged atoms. Influences electrostatic interactions, membrane permeability, and binding to negatively charged regions of targets. Many drugs contain basic (positively charged) functional groups.                                                                  |
| 20. | **RingCount** | 1.00     | 1.00        | 3.00     | 2.00 | 0.00    | ~30      | > 6 (7-30)                                   | Total number of rings (aliphatic and aromatic). Rings contribute to molecular rigidity, shape, and often drug-like properties. Too many rings can impact solubility and permeability.                                                                                               |
| 21. | **RotatableBonds** | 1.00     | 3.00        | 6.00     | 5.00 | ~0      | ~45      | > 13.5 (14-45)                               | Measure of molecular flexibility; high number can hinder tight binding, but allow conformational freedom. Impacts binding affinity and often oral bioavailability.                                                                                                                      |
| 22. | **TPSA** | 26.30    | 46.53       | 77.08    | 50.78 | ~0      | ~1000    | > 153.25 (155-1000)                          | Topological Polar Surface Area; correlates with passive molecular transport across membranes, predicting drug absorption and permeability. Lower values generally indicate better permeability.                                                                                         |

> The boxplots can be found at this [link](Plots/BoxPlots/)